CHOLMONDELEY PAULA H 4

What Happened

• Director Paula H. Cholmondeley received a grant of 35,000 derivative securities (reported as an award/acquisition) for Lexeo Therapeutics, Inc. (LXEO) on June 25, 2026. The reported acquisition price is $0.00; the award is recorded as a derivative grant rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-25 (Form 4 filed: 2026-06-29). Filing appears timely (within the standard two business‑day reporting window).
• Transaction type/code: A (award/grant of derivative securities).
• Amount: 35,000 shares underlying derivative awards; reported price $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — "100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date."

Context

• This is an equity award (derivative grant) subject to time‑based vesting; it is not an open‑market purchase or sale and does not indicate immediate liquidation. Such grants are common for director compensation and reflect future potential ownership contingent on continued service.